Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zhang, W; Wang, H; Song, SW; Fuller, GN
   Insulin-like growth factor binding protein 2: Gene expression microarrays and the hypothesis-generation paradigm
   BRAIN PATHOLOGY
   
   W. Zhang et al., "Insulin-like growth factor binding protein 2: Gene expression microarrays and the hypothesis-generation paradigm", BRAIN PATH, 12(1), 2002, pp. 87-94
2. Damstrup, L; Pedersen, MW; Bastholm, L; Elling, F; Poulsen, HS
   Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surfaceand enhances the malignant phenotype
   INTERNATIONAL JOURNAL OF CANCER
   
   L. Damstrup et al., "Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surfaceand enhances the malignant phenotype", INT J CANC, 97(1), 2002, pp. 7-14
3. Markert, JM; Fuller, CM; Gillespie, GY; Bubien, JK; McLean, LA; Hong, RL; Lee, K; Gullans, SR; Mapstone, TB; Benos, DJ
   Differential gene expression profiling in human brain tumors
   PHYSIOLOGICAL GENOMICS
   
   J.M. Markert et al., "Differential gene expression profiling in human brain tumors", PHYSIOL GEN, 5(1), 2001, pp. 21-33
4. Audero, E; Cascone, I; Zanon, I; Previtali, SC; Piva, R; Schiffer, D; Bussolino, F
   Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis - In vivo and in vitro studies
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   E. Audero et al., "Expression of angiopoietin-1 in human glioblastomas regulates tumor-induced angiogenesis - In vivo and in vitro studies", ART THROM V, 21(4), 2001, pp. 536-541
5. Chakravarti, A; Delaney, MA; Noll, E; Black, PM; Loffler, JS; Muzikansky, A; Dyson, NJ
   Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas
   CLINICAL CANCER RESEARCH
   
   A. Chakravarti et al., "Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas", CLIN CANC R, 7(8), 2001, pp. 2387-2395
6. Nakamura, M; Watanabe, T; Klangby, U; Asker, C; Wiman, K; Yonekawa, Y; Kleihues, P; Ohgaki, H
   p14(ARF) Deletion and methylation in genetic pathways to glioblastomas
   BRAIN PATHOLOGY
   
   M. Nakamura et al., "p14(ARF) Deletion and methylation in genetic pathways to glioblastomas", BRAIN PATH, 11(2), 2001, pp. 159-168
7. Mueller, W; Lass, U; Herms, J; Kuchelmeister, K; Bergmann, M; von Deimling, A
   Clonal analysis in glioblastoma with epithelial differentiation
   BRAIN PATHOLOGY
   
   W. Mueller et al., "Clonal analysis in glioblastoma with epithelial differentiation", BRAIN PATH, 11(1), 2001, pp. 39-43
8. Yoon, KS; Lee, MC; Kang, SS; Kim, JH; Jung, S; Kim, YJ; Lee, JH; Ahn, KY; Lee, JS; Cheon, JY
   p53 mutation and epidermal growth factor receptor overexpression in glioblastoma
   JOURNAL OF KOREAN MEDICAL SCIENCE
   
   K.S. Yoon et al., "p53 mutation and epidermal growth factor receptor overexpression in glioblastoma", J KOR MED S, 16(4), 2001, pp. 481-488
9. Chernova, OB; Hunyadi, A; Malaj, E; Pan, HQ; Crooks, C; Roe, B; Cowell, JK
   A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells
   ONCOGENE
   
   O.B. Chernova et al., "A novel member of the WD-repeat gene family, WDR11, maps to the 10q26 region and is disrupted by a chromosome translocation in human glioblastoma cells", ONCOGENE, 20(38), 2001, pp. 5378-5392
10. Fukuhara, H; Maruyama, T; Nomura, S; Oshimura, M; Kitamura, T; Sekiya, T; Murakami, Y
    Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers
    ONCOGENE
    
    H. Fukuhara et al., "Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers", ONCOGENE, 20(3), 2001, pp. 314-319
11. Nafe, R; Glienke, W; Schlote, W; Schneider, B
    EGFR gene amplification in glioblastomas - Is there a relationship with morphology of tumor cell nuclei and proliferative activity?
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    
    R. Nafe et al., "EGFR gene amplification in glioblastomas - Is there a relationship with morphology of tumor cell nuclei and proliferative activity?", ANAL QUAN C, 23(2), 2001, pp. 135-143
12. Loeper, S; Romeike, BFM; Heckmann, N; Jung, V; Henn, W; Feiden, W; Zang, KD; Urbschat, S
    Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas
    CYTOGENETICS AND CELL GENETICS
    
    S. Loeper et al., "Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas", CYTOG C GEN, 94(1-2), 2001, pp. 1-8
13. Kreuter, J
    Nanoparticulate systems for brain delivery of drugs
    ADVANCED DRUG DELIVERY REVIEWS
    
    J. Kreuter, "Nanoparticulate systems for brain delivery of drugs", ADV DRUG DE, 47(1), 2001, pp. 65-81
14. Bortolotto, S; Chiado-Piat, L; Cavalla, P; Bosone, I; Mauro, A; Schiffer, D
    CDKN2A/p16 in ependymomas
    JOURNAL OF NEURO-ONCOLOGY
    
    S. Bortolotto et al., "CDKN2A/p16 in ependymomas", J NEURO-ONC, 54(1), 2001, pp. 9-13
15. Nakamura, M; Watanabe, T; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G : C -> A : T mutations of the TP53 tumor suppressor gene
    CARCINOGENESIS
    
    M. Nakamura et al., "Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G : C -> A : T mutations of the TP53 tumor suppressor gene", CARCINOGENE, 22(10), 2001, pp. 1715-1719
16. DeAngelis, LM
    Medical progress: Brain tumors
    NEW ENGLAND JOURNAL OF MEDICINE
    
    L.M. DeAngelis, "Medical progress: Brain tumors", N ENG J MED, 344(2), 2001, pp. 114-123
17. Nakamura, M; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Promoter hypermethylation of the RB1 gene in glioblastomas
    LABORATORY INVESTIGATION
    
    M. Nakamura et al., "Promoter hypermethylation of the RB1 gene in glioblastomas", LAB INV, 81(1), 2001, pp. 77-82
18. Watanabe, T; Yokoo, H; Yokoo, M; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    T. Watanabe et al., "Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas", J NE EXP NE, 60(12), 2001, pp. 1181-1189
19. Burger, PC; Pearl, DK; Aldape, K; Yates, AJ; Scheithauer, BW; Passe, SM; Jenkins, RB; James, CD
    Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    P.C. Burger et al., "Small cell architecture - A histological equivalent of EGFR amplification in glioblastoma multiforme?", J NE EXP NE, 60(11), 2001, pp. 1099-1104
20. Darbinian, N; Gallia, GL; King, J; Del Valle, L; Johnson, EM; Khalili, K
    Growth inhibition of glioblastoma cells by human Pur alpha
    JOURNAL OF CELLULAR PHYSIOLOGY
    
    N. Darbinian et al., "Growth inhibition of glioblastoma cells by human Pur alpha", J CELL PHYS, 189(3), 2001, pp. 334-340
21. Luwor, RB; Johns, TG; Murone, C; Huang, HJS; Cavenee, WK; Ritter, G; Old, LJ; Burgess, AW; Scott, AM
    Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR
    CANCER RESEARCH
    
    R.B. Luwor et al., "Monoclonal antibody 806 inhibits the growth of tumor xenografts expressingeither the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR", CANCER RES, 61(14), 2001, pp. 5355-5361
22. Rickert, CH; Strater, R; Kaatsch, P; Wassmann, H; Jurgens, H; Dockhorn-Dworniczak, B; Paulus, W
    Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases
    AMERICAN JOURNAL OF PATHOLOGY
    
    C.H. Rickert et al., "Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases", AM J PATH, 158(4), 2001, pp. 1525-1532
23. Thomas, C; Ely, G; James, CD; Jenkins, R; Kastan, M; Jedlicka, A; Burger, P; Wharen, R
    Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells
    ACTA NEUROPATHOLOGICA
    
    C. Thomas et al., "Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells", ACT NEUROP, 101(6), 2001, pp. 605-615
24. Walker, C; Joyce, KA; Thompson-Hehir, J; Davies, MPA; Gibbs, FEM; Halliwell, N; Lloyd, BH; Machell, Y; Roebuck, MM; Salisbury, J; Sibson, DR; Du Plessis, D; Broome, J; Rossi, ML
    Characterisation of molecular alterations in microdissected archival gliomas
    ACTA NEUROPATHOLOGICA
    
    C. Walker et al., "Characterisation of molecular alterations in microdissected archival gliomas", ACT NEUROP, 101(4), 2001, pp. 321-333
25. Murakami, Y; Uejima, H; Fukuhara, H; Maruyama, T; Oshimura, M; Sekiya, T
    Construction of human-rodent hybrid cells containing single transferable fragments of human chromosome 10p
    JOURNAL OF HUMAN GENETICS
    
    Y. Murakami et al., "Construction of human-rodent hybrid cells containing single transferable fragments of human chromosome 10p", J HUM GENET, 45(6), 2000, pp. 370-373
26. Henson, JW
    Early genetic events in the formation of astrocytomas
    CURRENT OPINION IN NEUROLOGY
    
    J.W. Henson, "Early genetic events in the formation of astrocytomas", CURR OP NEU, 13(6), 2000, pp. 613-617
27. Yamada, K; Miura, M; Miyayama, H; Sakashita, N; Kochi, M; Ushio, Y
    Diffuse brainstem glioma in a patient with Laurence-Moon-(Bardet-)Biedl syndrome
    PEDIATRIC NEUROSURGERY
    
    K. Yamada et al., "Diffuse brainstem glioma in a patient with Laurence-Moon-(Bardet-)Biedl syndrome", PED NEUROS, 33(6), 2000, pp. 323-327
28. Sung, T; Miller, DC; Hayes, RL; Alonso, M; Yee, H; Newcomb, EW
    Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas
    BRAIN PATHOLOGY
    
    T. Sung et al., "Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas", BRAIN PATH, 10(2), 2000, pp. 249-259
29. Frenay, M; Lebrun, C; Lonjon, M; Bondiau, PY; Chatel, M
    Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas
    EUROPEAN JOURNAL OF CANCER
    
    M. Frenay et al., "Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas", EUR J CANC, 36(8), 2000, pp. 1026-1031
30. Leung, SY; Yuen, ST; Chan, TL; Chan, ASY; Ho, JWC; Kwan, K; Fan, YW; Hung, KN; Chung, LP; Wyllie, AH
    Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation
    ONCOGENE
    
    S.Y. Leung et al., "Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation", ONCOGENE, 19(35), 2000, pp. 4079-4083
31. Gary, SC; Zerillo, CA; Chiang, VL; Gaw, JU; Gray, G; Hockfield, S
    cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma
    GENE
    
    S.C. Gary et al., "cDNA cloning, chromosomal localization, and expression analysis of human BEHAB/brevican, a brain specific proteoglycan regulated during cortical development and in glioma", GENE, 256(1-2), 2000, pp. 139-147
32. McLean, LA; Roscoe, J; Jorgensen, NK; Gorin, FA; Cala, PM
    Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    
    L.A. McLean et al., "Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes", AM J P-CELL, 278(4), 2000, pp. C676-C688
33. Chong, EYY; Pang, JCS; Ko, CW; Poon, WS; Ng, HK
    Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas
    PATHOLOGY RESEARCH AND PRACTICE
    
    E.Y.Y. Chong et al., "Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas", PATH RES PR, 196(10), 2000, pp. 691-699
34. Tortosa, A; Ino, Y; Odell, N; Swilley, S; Sasaki, H; Louis, DN; Henson, JW
    Molecular genetics of radiographically defined de novo glioblastoma multiforme
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
    
    A. Tortosa et al., "Molecular genetics of radiographically defined de novo glioblastoma multiforme", NEUROP AP N, 26(6), 2000, pp. 544-552
35. Black, PM
    The present and future of cerebral tumor surgery in children
    CHILDS NERVOUS SYSTEM
    
    P.M. Black, "The present and future of cerebral tumor surgery in children", CHILD NERV, 16(10-11), 2000, pp. 821-828
36. Castro, MG; Cowen, R; Smith-Arica, J; Williams, J; Ali, S; Windeatt, S; Gonzalez-Nicolini, V; Maleniak, T; Lowenstein, PR
    Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas
    HISTOLOGY AND HISTOPATHOLOGY
    
    M.G. Castro et al., "Gene therapy strategies for intracranial tumours: glioma and pituitary adenomas", HIST HISTOP, 15(4), 2000, pp. 1233-1252
37. Gebhardt, F; Burger, H; Brandt, B
    Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations - a link between genetics and epigenetics
    HISTOLOGY AND HISTOPATHOLOGY
    
    F. Gebhardt et al., "Modulation of EGFR gene transcription by secondary structures, a polymorphic repetitive sequence and mutations - a link between genetics and epigenetics", HIST HISTOP, 15(3), 2000, pp. 929-936
38. Caskey, LS; Fuller, GN; Bruner, JM; Yung, WKA; Sawaya, RE; Holland, EC; Zhang, W
    Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling
    HISTOLOGY AND HISTOPATHOLOGY
    
    L.S. Caskey et al., "Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling", HIST HISTOP, 15(3), 2000, pp. 971-981
39. Kleihues, P; Ohgaki, H
    Phenotype vs genotype in the evolution of astrocytic brain tumors
    TOXICOLOGIC PATHOLOGY
    
    P. Kleihues e H. Ohgaki, "Phenotype vs genotype in the evolution of astrocytic brain tumors", TOX PATHOL, 28(1), 2000, pp. 164-170
40. Tews, DS; Nissen, A; Kulgen, C; Gaumann, AKA
    Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors
    JOURNAL OF NEURO-ONCOLOGY
    
    D.S. Tews et al., "Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors", J NEURO-ONC, 50(3), 2000, pp. 227-237
41. Nishimori, H; Nishikawa, R; Fujimaki, T; Nakagomi, T; Matsutani, M; Huang, HJS; Cavenee, WK
    Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors
    JOURNAL OF NEURO-ONCOLOGY
    
    H. Nishimori et al., "Analysis of the p300/CBP-Associated Factor (PCAF) gene in astrocytic tumors", J NEURO-ONC, 46(1), 2000, pp. 17-22
42. Jeuken, JWM; Nelen, MR; Vermeer, H; van Staveren, WCG; Kremer, H; van Overbeeke, JJ; Boerman, RH
    PTEN mutation analysis in two genetic subtypes of high-grade oligodendroglial tumors: PTEN is only occasionally mutated in one of the two genetic subtypes
    CANCER GENETICS AND CYTOGENETICS
    
    J.W.M. Jeuken et al., "PTEN mutation analysis in two genetic subtypes of high-grade oligodendroglial tumors: PTEN is only occasionally mutated in one of the two genetic subtypes", CANC GENET, 119(1), 2000, pp. 42-47
43. Sampson, JH; Crotty, LE; Lee, S; Archer, GE; Ashley, DM; Wikstrandt, CJ; Hale, LP; Small, C; Dranoff, G; Friedman, AH; Friedman, HS; Bigner, DD
    Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J.H. Sampson et al., "Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors", P NAS US, 97(13), 2000, pp. 7503-7508
44. Snitkovsky, S; Niederman, TMJ; Carter, BS; Mulligan, RC; Young, JAT
    A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor
    JOURNAL OF VIROLOGY
    
    S. Snitkovsky et al., "A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor", J VIROLOGY, 74(20), 2000, pp. 9540-9545
45. Badie, B; Schartner, JM; Paul, J; Bartley, BA; Vorpahl, J; Preston, JK
    Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study
    JOURNAL OF NEUROSURGERY
    
    B. Badie et al., "Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study", J NEUROSURG, 93(4), 2000, pp. 634-639
46. Kros, JM; Waarsenburg, N; Hayes, DP; Hop, WCJ; van Dekken, H
    Cytogenetic analysis of gemistocytic cells in gliomas
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    J.M. Kros et al., "Cytogenetic analysis of gemistocytic cells in gliomas", J NE EXP NE, 59(8), 2000, pp. 679-686
47. von Deimling, A; Fimmers, R; Schmidt, MC; Bender, B; Fassbender, F; Nagel, J; Jahnke, R; Kaskel, P; Duerr, EM; Koopmann, J; Maintz, D; Steinbeck, S; Wick, W; Platten, M; Muller, DJ; Przkora, R; Waha, A; Blumcke, B; Wellenreuther, R; Meyer-Puttlitz, B; Schmidt, O; Mollenhauer, J; Poustka, A; Stangl, AP; Lenartz, D; von Ammon, K; Henson, JW; Schramm, J; Louis, DN; Wiestler, OD
    Comprehensive allelotype and genetic analysis of 466 human nervous system tumors
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    A. von Deimling et al., "Comprehensive allelotype and genetic analysis of 466 human nervous system tumors", J NE EXP NE, 59(6), 2000, pp. 544-558
48. Liu, L; Ichimura, K; Pettersson, EH; Goike, HM; Collins, VP
    The complexity of the 7p12 amplicon in human astrocytic gliomas: Detailed mapping of 246 tumors
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    
    L. Liu et al., "The complexity of the 7p12 amplicon in human astrocytic gliomas: Detailed mapping of 246 tumors", J NE EXP NE, 59(12), 2000, pp. 1087-1093
49. Bortolotto, S; Chiado-Piat, L; Cavalla, P; Bosone, I; Chio, A; Mauro, A; Schiffer, D
    CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
    INTERNATIONAL JOURNAL OF CANCER
    
    S. Bortolotto et al., "CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas", INT J CANC, 88(4), 2000, pp. 554-557
50. Ichimura, K; Bolin, MB; Goike, HM; Schmidt, EE; Moshref, A; Collins, VP
    Deregulation of the p14(ARF)/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G(1)-S transition control gene abnormalities
    CANCER RESEARCH
    
    K. Ichimura et al., "Deregulation of the p14(ARF)/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G(1)-S transition control gene abnormalities", CANCER RES, 60(2), 2000, pp. 417-424
51. Tang, CK; Gong, XQ; Moscatello, DK; Wong, AJ; Lippman, ME
    Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer
    CANCER RESEARCH
    
    C.K. Tang et al., "Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer", CANCER RES, 60(11), 2000, pp. 3081-3087
52. Miyakawa, A; Ichimura, K; Schmidt, EE; Varmeh-Ziaie, S; Collins, VP
    Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours
    BRITISH JOURNAL OF CANCER
    
    A. Miyakawa et al., "Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours", BR J CANC, 82(3), 2000, pp. 543-549
53. Reis, RM; Konu-Lebleblicioglu, D; Lopes, JM; Kleihues, P; Ohgaki, H
    Genetic profile of gliosarcomas
    AMERICAN JOURNAL OF PATHOLOGY
    
    R.M. Reis et al., "Genetic profile of gliosarcomas", AM J PATH, 156(2), 2000, pp. 425-432
54. Hu, YC; Lam, KY; Tang, JCO; Srivastava, G
    Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamouscell carcinomas
    JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    
    Y.C. Hu et al., "Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamouscell carcinomas", J CL PATH-M, 52(6), 1999, pp. 353-356
55. Hahn, M; Wieland, I; Koufaki, ON; Gorgens, H; Sobottka, SB; Schackert, G; Schackert, HK
    Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brainmetastases
    CLINICAL CANCER RESEARCH
    
    M. Hahn et al., "Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brainmetastases", CLIN CANC R, 5(9), 1999, pp. 2431-2437
56. Meneses, PI; Abrey, LE; Hajjar, KA; Gultekin, SH; Duvoisin, RM; Berns, KI; Rosenfeld, MR
    Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth
    CLINICAL CANCER RESEARCH
    
    P.I. Meneses et al., "Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth", CLIN CANC R, 5(11), 1999, pp. 3689-3694
57. Fan, X; Gomez, L; Nistal, M; Sierrasesumaga, L; Castresana, JS
    Lack of gene amplification as a mechanism of CDK4 activation in human neuroblastoma
    ONCOLOGY REPORTS
    
    X. Fan et al., "Lack of gene amplification as a mechanism of CDK4 activation in human neuroblastoma", ONCOL REP, 6(3), 1999, pp. 647-650
58. Buschges, R; Weber, RG; Actor, B; Lichter, P; Collins, VP; Reifenberger, G
    Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) inhuman malignant gliomas
    BRAIN PATHOLOGY
    
    R. Buschges et al., "Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) inhuman malignant gliomas", BRAIN PATH, 9(3), 1999, pp. 435-442
59. Ishii, N; Maier, D; Merlo, A; Tada, M; Sawamura, Y; Diserens, AC; Van Meir, EG
    Frequent co-alterations of TP53, p16/CDKN2A, p14(ARF), PTEN tumor suppressor genes in human glioma cell lines.
    BRAIN PATHOLOGY
    
    N. Ishii et al., "Frequent co-alterations of TP53, p16/CDKN2A, p14(ARF), PTEN tumor suppressor genes in human glioma cell lines.", BRAIN PATH, 9(3), 1999, pp. 469-479
60. Fisher, GH; Orsulic, S; Holland, E; Hively, WP; Li, Y; Lewis, BC; Williams, BO; Varmus, HE
    Development of a flexible and specific gene delivery system for productionof murine tumor models
    ONCOGENE
    
    G.H. Fisher et al., "Development of a flexible and specific gene delivery system for productionof murine tumor models", ONCOGENE, 18(38), 1999, pp. 5253-5260
61. Schlegel, J; Piontek, G; Kuhne, C; Bartels, HJ; Kraus, A; Kappler, R; Mennel, HD
    Molecular genetic characterisation of intracerebrally transplanted brain tumours
    EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    
    J. Schlegel et al., "Molecular genetic characterisation of intracerebrally transplanted brain tumours", EXP TOX PAT, 51(1), 1999, pp. 41-45
62. Saito, A; Nakazato, Y
    Evaluation of malignant features in oligodendroglial tumors
    CLINICAL NEUROPATHOLOGY
    
    A. Saito e Y. Nakazato, "Evaluation of malignant features in oligodendroglial tumors", CLIN NEUR, 18(2), 1999, pp. 61-73
63. Loiseau, H; Arsaut, J; Demotes-Mainard, J
    p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas
    NEUROSCIENCE LETTERS
    
    H. Loiseau et al., "p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas", NEUROSCI L, 263(2-3), 1999, pp. 173-176
64. Maruno, M; Yoshimine, T; Muhammad, AKMG; Ninomiya, H; Kato, A; Hayakawa, T
    Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors
    CANCER LETTERS
    
    M. Maruno et al., "Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors", CANCER LETT, 135(1), 1999, pp. 61-66
65. Napolitano, M; Keime-Guibert, F; Monjour, A; Lafitte, C; Ameri, A; Cornu, P; Broet, P; Delattre, JY
    Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study
    JOURNAL OF NEURO-ONCOLOGY
    
    M. Napolitano et al., "Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study", J NEURO-ONC, 45(3), 1999, pp. 229-235
66. Onda, K; Nagai, S; Tanaka, R; Morii, K; Yoshimura, J; Tsumanuma, I; Kumanishi, T
    Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual
    JOURNAL OF NEURO-ONCOLOGY
    
    K. Onda et al., "Establishment of two glioma cell lines from two surgical specimens obtained at different times from the same individual", J NEURO-ONC, 41(3), 1999, pp. 247-254
67. Cheng, Y; Ng, HK; Zhang, SF; Ding, M; Pang, JCS; Zheng, J; Poon, WS
    Genetic alterations in pediatric high-grade astrocytomas
    HUMAN PATHOLOGY
    
    Y. Cheng et al., "Genetic alterations in pediatric high-grade astrocytomas", HUMAN PATH, 30(11), 1999, pp. 1284-1290
68. Peraud, A; Watanabe, K; Schwechheimer, K; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Genetic profile of the giant cell glioblastoma
    LABORATORY INVESTIGATION
    
    A. Peraud et al., "Genetic profile of the giant cell glioblastoma", LAB INV, 79(2), 1999, pp. 123-129
69. Besson, A; Robbins, SM; Yong, VW
    PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    A. Besson et al., "PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis", EUR J BIOCH, 263(3), 1999, pp. 605-611
70. Riemenschneider, MJ; Buschges, R; Wolter, M; Reifenberger, J; Bostrom, J; Kraus, JA; Schlegel, U; Reifenberger, G
    Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification
    CANCER RESEARCH
    
    M.J. Riemenschneider et al., "Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification", CANCER RES, 59(24), 1999, pp. 6091-6096
71. Marutani, M; Tonoki, H; Tada, M; Takahashi, M; Kashiwazaki, H; Hida, Y; Hamada, J; Asaka, M; Moriuchi, T
    Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme
    CANCER RESEARCH
    
    M. Marutani et al., "Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme", CANCER RES, 59(19), 1999, pp. 4765-4769
72. Harada, H; Nakagawa, K; Iwata, S; Saito, M; Kumon, Y; Sakaki, S; Sato, K; Hamada, K
    Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas
    CANCER RESEARCH
    
    H. Harada et al., "Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas", CANCER RES, 59(15), 1999, pp. 3783-3789
73. Hill, JR; Kuriyama, N; Kuriyama, H; Israel, MA
    Molecular genetics of brain tumors
    ARCHIVES OF NEUROLOGY
    
    J.R. Hill et al., "Molecular genetics of brain tumors", ARCH NEUROL, 56(4), 1999, pp. 439-441
74. Fujisawa, H; Kurrer, M; Reis, RM; Yonekawa, Y; Kleihues, P; Ohgaki, H
    Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter
    AMERICAN JOURNAL OF PATHOLOGY
    
    H. Fujisawa et al., "Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter", AM J PATH, 155(2), 1999, pp. 387-394
75. Brat, DJ; James, CD; Jedlicka, AE; Connolly, DC; Chang, E; Castellani, RJ; Schmid, M; Schiller, M; Carson, DA; Burger, PC
    Molecular genetic alterations in radiation-induced astrocytomas
    AMERICAN JOURNAL OF PATHOLOGY
    
    D.J. Brat et al., "Molecular genetic alterations in radiation-induced astrocytomas", AM J PATH, 154(5), 1999, pp. 1431-1438
76. An, HX; Beckmann, MW; Reifenberger, G; Bender, HG; Niederacher, D
    Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation
    AMERICAN JOURNAL OF PATHOLOGY
    
    H.X. An et al., "Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation", AM J PATH, 154(1), 1999, pp. 113-118
77. Ohgaki, H; Watanabe, K; Peraud, A; Biernat, W; von Deimling, A; Yasargil, MG; Yonekawa, Y; Kleihues, P
    A case history of glioma progression
    ACTA NEUROPATHOLOGICA
    
    H. Ohgaki et al., "A case history of glioma progression", ACT NEUROP, 97(5), 1999, pp. 525-532
78. WIKSTRAND CJ; REIST CJ; ARCHER GE; ZALUTSKY MR; BIGNER DD
    THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS
    Journal of neurovirology
    
    C.J. Wikstrand et al., "THE CLASS-III VARIANT OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFRVIII) - CHARACTERIZATION AND UTILIZATION AS AN IMMUNOTHERAPEUTIC TARGETS", Journal of neurovirology, 4(2), 1998, pp. 148-158
79. Darling, JL; Warr, TJ
    Biology and genetics of malignant brain tumours
    CURRENT OPINION IN NEUROLOGY
    
    J.L. Darling e T.J. Warr, "Biology and genetics of malignant brain tumours", CURR OP NEU, 11(6), 1998, pp. 619-625
80. ZHAO QH; BLOMQUIST E; BOLANDER H; GEDDA L; HARTVIG P; JANSON JC; LUNDQVIST H; MELLSTEDT H; NILSSON S; NISTER M; SUNDIN A; TOLMACHEV V; WESTLIN JE; CARLSSON J
    CONJUGATE CHEMISTRY, IODINATION AND CELLULAR-BINDING OF MEGF-DEXTRAN-TYROSINE - PRECLINICAL TESTS IN PREPARATION FOR CLINICAL-TRIALS
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    Q.H. Zhao et al., "CONJUGATE CHEMISTRY, IODINATION AND CELLULAR-BINDING OF MEGF-DEXTRAN-TYROSINE - PRECLINICAL TESTS IN PREPARATION FOR CLINICAL-TRIALS", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(4), 1998, pp. 693-702
81. Suzuki, H; Fujioka, Y
    Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland
    DIAGNOSTIC MOLECULAR PATHOLOGY
    
    H. Suzuki e Y. Fujioka, "Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland", DIAGN MOL P, 7(4), 1998, pp. 224-231
82. FUEYO J; GOMEZMANZANO C; PUDUVALLI VK; MARTINDUQUE P; PEREZSOLER R; LEVIN VA; YUNG WKA; KYRITSIS AP
    ADENOVIRUS-MEDIATED P16 TRANSFER TO GLIOMA-CELLS INDUCES G(1) ARREST AND PROTECTS FROM PACLITAXEL AND TOPOTECAN - IMPLICATIONS FOR THERAPY
    International journal of oncology
    
    J. Fueyo et al., "ADENOVIRUS-MEDIATED P16 TRANSFER TO GLIOMA-CELLS INDUCES G(1) ARREST AND PROTECTS FROM PACLITAXEL AND TOPOTECAN - IMPLICATIONS FOR THERAPY", International journal of oncology, 12(3), 1998, pp. 665-669
83. PIVA R; CAVALLA P; BORTOLOTTO S; CORDERA S; GROSSO R; RICHIARDI P; DUTTO A; SCHIFFER D
    CDKN2 P16 INACTIVATION AND P16 IMMUNOHISTOCHEMISTRY IN ASTROCYTIC GLIOMAS/
    International journal of oncology
    
    R. Piva et al., "CDKN2 P16 INACTIVATION AND P16 IMMUNOHISTOCHEMISTRY IN ASTROCYTIC GLIOMAS/", International journal of oncology, 12(1), 1998, pp. 55-58
84. PETERSEN S; RUDOLF J; BOCKMUHL U; GELLERT K; WOLF G; DIETEL M; PETERSEN I
    DISTINCT REGIONS OF ALLELIC IMBALANCE ON CHROMOSOME 10Q22-Q26 IN SQUAMOUS-CELL CARCINOMAS OF THE LUNG
    Oncogene
    
    S. Petersen et al., "DISTINCT REGIONS OF ALLELIC IMBALANCE ON CHROMOSOME 10Q22-Q26 IN SQUAMOUS-CELL CARCINOMAS OF THE LUNG", Oncogene, 17(4), 1998, pp. 449-454
85. KIM SK; RO JY; KEMP BL; LEE JS; KWON TJ; HONG WK; MAO L
    IDENTIFICATION OF 2 DISTINCT TUMOR-SUPPRESSOR LOCI ON THE LONG ARM OFCHROMOSOME-10 IN SMALL-CELL LUNG-CANCER
    Oncogene
    
    S.K. Kim et al., "IDENTIFICATION OF 2 DISTINCT TUMOR-SUPPRESSOR LOCI ON THE LONG ARM OFCHROMOSOME-10 IN SMALL-CELL LUNG-CANCER", Oncogene, 17(13), 1998, pp. 1749-1753
86. OROURKE DM; NUTE EJL; DAVIS JG; WU CJ; LEE A; MURALI R; ZHANG HT; QIAN XL; KAO CC; GREENE MI
    INHIBITION OF A NATURALLY-OCCURRING EGFR ONCOPROTEIN BY THE P185NEU ECTODOMAIN - IMPLICATIONS FOR SUBDOMAIN CONTRIBUTIONS TO RECEPTOR ASSEMBLY
    Oncogene
    
    D.M. Orourke et al., "INHIBITION OF A NATURALLY-OCCURRING EGFR ONCOPROTEIN BY THE P185NEU ECTODOMAIN - IMPLICATIONS FOR SUBDOMAIN CONTRIBUTIONS TO RECEPTOR ASSEMBLY", Oncogene, 16(9), 1998, pp. 1197-1207
87. Holland, EC; Hively, WP; Gallo, V; Varmus, HE
    Modeling mutations in the G(1) arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes
    GENES & DEVELOPMENT
    
    E.C. Holland et al., "Modeling mutations in the G(1) arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes", GENE DEV, 12(23), 1998, pp. 3644-3649
88. SPETZGER U; THRON A; GILSBACH JM
    IMMEDIATE POSTOPERATIVE CT CONTRAST ENHANCEMENT FOLLOWING SURGERY OF CEREBRAL TUMORAL LESIONS
    Journal of computer assisted tomography
    
    U. Spetzger et al., "IMMEDIATE POSTOPERATIVE CT CONTRAST ENHANCEMENT FOLLOWING SURGERY OF CEREBRAL TUMORAL LESIONS", Journal of computer assisted tomography, 22(1), 1998, pp. 120-125
89. BOUVIERLABIT C; CHINOT O; OCHI C; GAMBARELLI D; DUFOURT H; FIGARELLABRANGER D
    PROGNOSTIC-SIGNIFICANCE OF KI67, P53 AND EPIDERMAL GROWTH-FACTOR RECEPTOR IMMUNOSTAINING IN HUMAN GLIOBLASTOMAS
    Neuropathology and applied neurobiology
    
    C. Bouvierlabit et al., "PROGNOSTIC-SIGNIFICANCE OF KI67, P53 AND EPIDERMAL GROWTH-FACTOR RECEPTOR IMMUNOSTAINING IN HUMAN GLIOBLASTOMAS", Neuropathology and applied neurobiology, 24(5), 1998, pp. 381-388
90. STILES CD
    CANCER OF THE CENTRAL-NERVOUS-SYSTEM - REVIEW OF AN AACR SPECIAL CONFERENCE IN CANCER-RESEARCH WITH THE JOINT SECTION ON TUMORS OF THE AANSCNS (SAN-DIEGO, CA, JUNE 7-11, 1997)/
    Biochimica et biophysica acta, CR. Reviews on cancer
    
    C.D. Stiles, "CANCER OF THE CENTRAL-NERVOUS-SYSTEM - REVIEW OF AN AACR SPECIAL CONFERENCE IN CANCER-RESEARCH WITH THE JOINT SECTION ON TUMORS OF THE AANSCNS (SAN-DIEGO, CA, JUNE 7-11, 1997)/", Biochimica et biophysica acta, CR. Reviews on cancer, 1377(1), 1998, pp. 1-10
91. BRISTOT R; RACO A; VANGELISTA T; DELFINI R
    MALIGNANT CEREBELLAR ASTROCYTOMAS IN CHILDHOOD - EXPERIENCE WITH 4 CASES
    Child's nervous system
    
    R. Bristot et al., "MALIGNANT CEREBELLAR ASTROCYTOMAS IN CHILDHOOD - EXPERIENCE WITH 4 CASES", Child's nervous system, 14(10), 1998, pp. 532-536
92. KNUPFER MM; POPPENBORG H; HOTFILDER M; DOMULA M; WOLFF JEA
    HYALURONIC-ACID BINDING-CAPACITY OF MALIGNANT GLIOMA-CELLS
    Anticancer research
    
    M.M. Knupfer et al., "HYALURONIC-ACID BINDING-CAPACITY OF MALIGNANT GLIOMA-CELLS", Anticancer research, 18(1A), 1998, pp. 353-356
93. SUGAWA N; UEDA S; NAKAGAWA Y; NISHINO H; NOSAKA K; IWASHIMA A; KURIMOTO M
    AN ANTISENSE EGFR OLIGODEOXYNUCLEOTIDE ENVELOPED IN LIPOFECTIN(R) INDUCES GROWTH-INHIBITION IN HUMAN-MALIGNANT GLIOMAS IN-VITRO
    Journal of neuro-oncology
    
    N. Sugawa et al., "AN ANTISENSE EGFR OLIGODEOXYNUCLEOTIDE ENVELOPED IN LIPOFECTIN(R) INDUCES GROWTH-INHIBITION IN HUMAN-MALIGNANT GLIOMAS IN-VITRO", Journal of neuro-oncology, 39(3), 1998, pp. 237-244
94. NYGAARD SJT; HAUGLAND HK; KRISTOFFERSEN EK; LUNDJOHANSEN M; LAERUM OD; TYSNES OB
    EXPRESSION OF ANNEXIN-II IN GLIOMA CELL-LINES AND IN BRAIN-TUMOR BIOPSIES
    Journal of neuro-oncology
    
    S.J.T. Nygaard et al., "EXPRESSION OF ANNEXIN-II IN GLIOMA CELL-LINES AND IN BRAIN-TUMOR BIOPSIES", Journal of neuro-oncology, 38(1), 1998, pp. 11-18
95. CHERNOVA O; COWELL JK
    MOLECULAR DEFINITION OF CHROMOSOME TRANSLOCATIONS INVOLVING 10Q24 AND19Q13 IN HUMAN-MALIGNANT GLIOMA-CELLS
    Cancer genetics and cytogenetics
    
    O. Chernova e J.K. Cowell, "MOLECULAR DEFINITION OF CHROMOSOME TRANSLOCATIONS INVOLVING 10Q24 AND19Q13 IN HUMAN-MALIGNANT GLIOMA-CELLS", Cancer genetics and cytogenetics, 105(1), 1998, pp. 60-68
96. RIEGER L; WELLER M; BORNEMANN A; SCHABET M; DICHGANS J; MEYERMANN R
    BCL-2 FAMILY PROTEIN EXPRESSION IN HUMAN-MALIGNANT GLIOMA - A CLINICAL-PATHOLOGICAL CORRELATIVE STUDY
    Journal of the neurological sciences
    
    L. Rieger et al., "BCL-2 FAMILY PROTEIN EXPRESSION IN HUMAN-MALIGNANT GLIOMA - A CLINICAL-PATHOLOGICAL CORRELATIVE STUDY", Journal of the neurological sciences, 155(1), 1998, pp. 68-75
97. SCHMIDT M; REISER P; HILLS D; GULLICK WJ; WELS W
    EXPRESSION OF AN ONCOGENIC MUTANT EGF RECEPTOR MARKEDLY INCREASES THESENSITIVITY OF CELLS TO AN EGF-RECEPTOR-SPECIFIC ANTIBODY-TOXIN
    International journal of cancer
    
    M. Schmidt et al., "EXPRESSION OF AN ONCOGENIC MUTANT EGF RECEPTOR MARKEDLY INCREASES THESENSITIVITY OF CELLS TO AN EGF-RECEPTOR-SPECIFIC ANTIBODY-TOXIN", International journal of cancer, 75(6), 1998, pp. 878-884
98. LEUNG SY; CHAN TL; CHUNG LP; CHAN ASY; FAN YW; HUNG KN; KWONG WK; HO JWC; YUEN ST
    MICROSATELLITE INSTABILITY AND MUTATION OF DNA MISMATCH REPAIR GENES IN GLIOMAS
    The American journal of pathology
    
    S.Y. Leung et al., "MICROSATELLITE INSTABILITY AND MUTATION OF DNA MISMATCH REPAIR GENES IN GLIOMAS", The American journal of pathology, 153(4), 1998, pp. 1181-1188
99. KORKOLOPOULOU P; KOUZELIS K; CHRISTODOULOU P; PAPANIKOLAOU A; THOMASTSAGLI E
    EXPRESSION OF RETINOBLASTOMA GENE-PRODUCT AND P21 (WAF1 CIP-1) PROTEIN IN GLIOMAS - CORRELATIONS WITH PROLIFERATION MARKERS, P53 EXPRESSIONAND SURVIVAL/
    Acta Neuropathologica
    
    P. Korkolopoulou et al., "EXPRESSION OF RETINOBLASTOMA GENE-PRODUCT AND P21 (WAF1 CIP-1) PROTEIN IN GLIOMAS - CORRELATIONS WITH PROLIFERATION MARKERS, P53 EXPRESSIONAND SURVIVAL/", Acta Neuropathologica, 95(6), 1998, pp. 617-624
100. CAVALLA P; DUTTO A; PIVA R; RICHIARDI P; GROSSO R; SCHIFFER D
     CYCLIN D1 EXPRESSION IN GLIOMAS
     Acta Neuropathologica
     
     P. Cavalla et al., "CYCLIN D1 EXPRESSION IN GLIOMAS", Acta Neuropathologica, 95(2), 1998, pp. 131-135